IRIS Accounts Production v24.3.2.46 06072635 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh060726352023-03-31060726352024-03-31060726352023-04-012024-03-31060726352022-03-31060726352022-04-012023-03-31060726352023-03-3106072635ns15:EnglandWales2023-04-012024-03-3106072635ns14:PoundSterling2023-04-012024-03-3106072635ns10:Director12023-04-012024-03-3106072635ns10:Director22023-04-012024-03-3106072635ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106072635ns10:SmallEntities2023-04-012024-03-3106072635ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3106072635ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106072635ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106072635ns10:FullAccounts2023-04-012024-03-310607263512023-04-012024-03-3106072635ns5:CurrentFinancialInstruments2024-03-3106072635ns5:CurrentFinancialInstruments2023-03-3106072635ns5:Non-currentFinancialInstruments2024-03-3106072635ns5:Non-currentFinancialInstruments2023-03-3106072635ns5:ShareCapital2024-03-3106072635ns5:ShareCapital2023-03-3106072635ns5:RetainedEarningsAccumulatedLosses2024-03-3106072635ns5:RetainedEarningsAccumulatedLosses2023-03-3106072635ns10:RegisteredOffice2023-04-012024-03-3106072635ns5:NetGoodwill2023-04-012024-03-3106072635ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3106072635ns5:LandBuildings2023-04-012024-03-3106072635ns5:PlantMachinery2023-04-012024-03-3106072635ns5:NetGoodwill2023-03-3106072635ns5:NetGoodwill2024-03-3106072635ns5:NetGoodwill2023-03-3106072635ns5:LandBuildings2023-03-3106072635ns5:PlantMachinery2023-03-3106072635ns5:FurnitureFittings2023-03-3106072635ns5:FurnitureFittings2023-04-012024-03-3106072635ns5:LandBuildings2024-03-3106072635ns5:PlantMachinery2024-03-3106072635ns5:FurnitureFittings2024-03-3106072635ns5:LandBuildings2023-03-3106072635ns5:PlantMachinery2023-03-3106072635ns5:FurnitureFittings2023-03-3106072635ns5:MotorVehicles2023-03-3106072635ns5:ComputerEquipment2023-03-3106072635ns5:MotorVehicles2023-04-012024-03-3106072635ns5:ComputerEquipment2023-04-012024-03-3106072635ns5:MotorVehicles2024-03-3106072635ns5:ComputerEquipment2024-03-3106072635ns5:MotorVehicles2023-03-3106072635ns5:ComputerEquipment2023-03-3106072635ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3106072635ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106072635ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-3106072635ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-03-3106072635ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3106072635ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-3106072635ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-03-3106072635ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-03-3106072635ns5:RetainedEarningsAccumulatedLosses2023-03-3106072635ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31
REGISTERED NUMBER: 06072635 (England and Wales)










Financial Statements

for the Year Ended 31 March 2024

for

Health Pharm (Leicester) Limited

Health Pharm (Leicester) Limited (Registered number: 06072635)

Contents of the Financial Statements
for the Year Ended 31 March 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


Health Pharm (Leicester) Limited (Registered number: 06072635)

Balance Sheet
31 March 2024

31.3.24 31.3.23
Notes £    £    £    £   
Fixed assets
Intangible assets 4 1 1
Tangible assets 5 560,271 612,734
560,272 612,735

Current assets
Stocks 1,309,755 1,314,673
Debtors 6 1,150,582 869,722
Cash at bank and in hand 6,926 221,361
2,467,263 2,405,756
Creditors
Amounts falling due within one year 7 657,299 723,554
Net current assets 1,809,964 1,682,202
Total assets less current liabilities 2,370,236 2,294,937

Creditors
Amounts falling due after more than one
year

8

(413,892

)

(479,226

)

Provisions for liabilities (86,104 ) (91,605 )
Net assets 1,870,240 1,724,106

Capital and reserves
Called up share capital 100 100
Retained earnings 9 1,870,140 1,724,006
Shareholders' funds 1,870,240 1,724,106

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Health Pharm (Leicester) Limited (Registered number: 06072635)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 February 2025 and were signed on its behalf by:




A Patel - Director



K Amin - Director


Health Pharm (Leicester) Limited (Registered number: 06072635)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. Statutory information

Health Pharm (Leicester) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06072635

Registered office: 465-467 Saffron Lane
Leicester
LE2 6UG

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2007, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 50 years
Plant and machinery etc - 33% on reducing balance and 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Health Pharm (Leicester) Limited (Registered number: 06072635)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


2. Accounting policies - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 41 (2023 - 41 ) .

4. Intangible fixed assets
Goodwill
£   
Cost
At 1 April 2023
and 31 March 2024 1,948,068
Amortisation
At 1 April 2023
and 31 March 2024 1,948,067
Net book value
At 31 March 2024 1
At 31 March 2023 1

Health Pharm (Leicester) Limited (Registered number: 06072635)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


5. Tangible fixed assets
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
Cost
At 1 April 2023
and 31 March 2024 252,555 366,582 124,244
Depreciation
At 1 April 2023 30,264 221,636 72,270
Charge for year 5,051 39,383 -
At 31 March 2024 35,315 261,019 72,270
Net book value
At 31 March 2024 217,240 105,563 51,974
At 31 March 2023 222,291 144,946 51,974

Motor Computer
vehicles equipment Totals
£    £    £   
Cost
At 1 April 2023
and 31 March 2024 214,579 25,970 983,930
Depreciation
At 1 April 2023 23,065 23,961 371,196
Charge for year 7,366 663 52,463
At 31 March 2024 30,431 24,624 423,659
Net book value
At 31 March 2024 184,148 1,346 560,271
At 31 March 2023 191,514 2,009 612,734

6. Debtors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Trade debtors 664,522 162,557
Other debtors 344,899 549,959
Directors' current accounts - 1
VAT 141,161 157,205
1,150,582 869,722

Health Pharm (Leicester) Limited (Registered number: 06072635)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


7. Creditors: amounts falling due within one year
31.3.24 31.3.23
£    £   
Bank loans and overdrafts 206,608 206,608
Trade creditors 289,043 362,520
Tax 126,010 132,084
Social security and other taxes 17,259 18,446
Pension control 9,195 3,895
Wages control 2,517 -
Directors' current accounts - 1
Accrued expenses 6,667 -
657,299 723,554

8. Creditors: amounts falling due after more than one year
31.3.24 31.3.23
£    £   
Bank loan - 1-2 years 103,304 103,304
Bank loan - 2-5 years 289,954 289,954
Bank loans more than 5 yrs 20,634 85,968
413,892 479,226

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more than 5 yrs 20,634 85,968

9. Reserves
Retained
earnings
£   

At 1 April 2023 1,724,006
Profit for the year 286,134
Dividends (140,000 )
At 31 March 2024 1,870,140